Further medicines added to the list of medicines that cannot be parallel exported from the UK

Further medicines added to the list of medicines that cannot be parallel exported from the UK

May 12, 2020

The Department of Health and Social Care (DHSC) and the Medicines and Healthcare products Regulatory Agency (MHRA) has announced that an additional 33 medicines have been added to the list of medicines which must not be parallel exported from the UK. The additional restrictions came into place from 00:00am 24 April 2020.

The new restrictions cover specified pharmaceutical forms and strengths of medicines including:

  • Atenolol
  • Azithromycin
  • Bisoprolol
  • Buprenorphine
  • Dexamethasone
  • Digoxin
  • Glycopyrronium bromide
  • Ibuprofen
  • Lisinopril
  • Metoprolol
  • Tiotropium

View the latest list of medicines that cannot be parallel exported from the UK (updated 24/04/20)

The list, will continue to be reviewed on an ongoing basis, to include any product that meets the following criteria:

  1. the medicine is required to meet the needs of UK patients;
  2. the medicine is either being parallel exported or is at threat of being parallel exported; and
  3. the export of that medicine is either contributing to, or may contribute to, a shortage of that medicine in the UK.



Posted in: ,


More Latest News >